Literature DB >> 33970867

Characteristics of Citizens and Their Use of Teleconsultations in Primary Care in the Catalan Public Health System Before and During the COVID-19 Pandemic: Retrospective Descriptive Cross-sectional Study.

Oscar Solans1,2, Josep Vidal-Alaball3,4,5, Pasqual Roig Cabo6, Núria Mora7, Ermengol Coma7, Josep Maria Bonet Simó6, Eduardo Hermosilla Pérez7,8, Francesc Saigí-Rubió9,10, Carmen Olmos Domínguez1, Jordi Piera-Jiménez2,11,12, Mercè Abizanda González13,14, Francesc López Seguí6,15.   

Abstract

BACKGROUND: eConsulta-that is, asynchronous, two-way teleconsultation in primary care-is one of the most important telemedicine developments in the Catalan public health system, a service that has been heavily boosted by the onset of the COVID-19 pandemic. It is vital to know the characteristics of its users in order to be able to meet their needs and understand the coverage of this service in a context where there is reduced accessibility to the health system.
OBJECTIVE: This study aims to analyze the profile of the citizens who use the eConsulta tool and the reasons for their use, as well as to gain an understanding of the elements that characterize their decision to use it while distinguishing between those who used it before and those who have used it since the onset of the COVID-19 pandemic.
METHODS: A descriptive, observational study based on administrative data was performed. This study differentiates between the COVID-19 pandemic era and the period preceding it, considering the day the state of emergency was declared in Spain (ie, March 12, 2020) as the cut-off point. It also differentiates between eConsulta users who send messages and those who only receive them.
RESULTS: During the pandemic, the number of unique users of this teleconsultation service had almost tripled, with up to 33.10 visits per 1000 inhabitants per month reported in the first three months. For the two user profiles analyzed, most users since the start of the COVID-19 outbreak were predominantly female, systematically younger, more actively employed, and with less complex pathologies. Furthermore, eConsulta users received more messages proactively from the health professionals. There was also a relative decrease in the number of conversations initiated by higher-income urban users and an increase in conversations initiated by users in rural areas.
CONCLUSIONS: The COVID-19 pandemic has helped to generalize the use of telemedicine as a tool to compensate, to some extent, for the decline in face-to-face visits, especially among younger citizens in Catalonia. Telemedicine has made it possible to maintain contact between citizens and the health care system in the context of maximum complexity. ©Oscar Solans, Josep Vidal-Alaball, Pasqual Roig Cabo, Núria Mora, Ermengol Coma, Josep Maria Bonet Simó, Eduardo Hermosilla Pérez, Francesc Saigí-Rubió, Carmen Olmos Domínguez, Jordi Piera-Jiménez, Mercè Abizanda González, Francesc López Seguí. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 27.05.2021.

Entities:  

Keywords:  COVID-19; e-consultation; primary care; remote consultation; teleconsultation; telehealth

Year:  2021        PMID: 33970867     DOI: 10.2196/28629

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   5.428


  9 in total

1.  [Accessibility and Digital Divide, the 2.0 Inverse Care Law].

Authors:  Esther Díaz Salcedo; Josep Vidal Alaball
Journal:  Aten Primaria       Date:  2022-10       Impact factor: 2.206

2.  [Impact of the COVID-19 pandemic on healthcare provided from Primary Care in a healthcare area].

Authors:  J Escribano-Serrano; E Jiménez-Varo; C Casto-Jarillo; A Hormigo-Pozo; A Michán-Doña
Journal:  Semergen       Date:  2022-04-29

3.  Association between the reduction of face-to-face appointments and the control of patients with type 2 diabetes mellitus during the Covid-19 pandemic in Catalonia.

Authors:  Ermengol Coma; Queralt Miró; Manuel Medina; Francesc X Marin-Gomez; Xavier Cos; Mència Benítez; Ariadna Mas; Mireia Fàbregas; Francesc Fina; Yolanda Lejardi; Josep Vidal-Alaball
Journal:  Diabetes Res Clin Pract       Date:  2021-11-06       Impact factor: 8.180

4.  [Primary care organization in pandemic times].

Authors:  Txema Coll Benejam; Jesús Palacio Lapuente; Rosa Añel Rodríguez; Montse Gens Barbera; Juan José Jurado Balbuena; Aina Perelló Bratescu
Journal:  Aten Primaria       Date:  2021-11-19       Impact factor: 1.137

5.  Asynchronous Remote Communication as a Tool for Care Management in Primary Care: A Rapid Review of the Literature.

Authors:  Aïna Fuster-Casanovas; Josep Vidal-Alaball
Journal:  Int J Integr Care       Date:  2022-08-11       Impact factor: 2.913

Review 6.  Digital Facilitation to Support Patient Access to Web-Based Primary Care Services: Scoping Literature Review.

Authors:  Brandi Leach; Sarah Parkinson; Evangelos Gkousis; Gary Abel; Helen Atherton; John Campbell; Christopher Clark; Emma Cockcroft; Christine Marriott; Emma Pitchforth; Jon Sussex
Journal:  J Med Internet Res       Date:  2022-07-14       Impact factor: 7.076

7.  Factors Associated With the Utilization of Outpatient Virtual Clinics: Retrospective Observational Study Using Multilevel Analysis.

Authors:  Wei-Hsian Yin; Hui-Chu Lang; Yun-Hsuan Tzeng; Kuan-Chia Lin; Jeng Wei; Hao-Ren Liou; Hung-Ju Sung
Journal:  J Med Internet Res       Date:  2022-08-12       Impact factor: 7.076

8.  Missing Diagnoses during the COVID-19 Pandemic: A Year in Review.

Authors:  Héctor Pifarré I Arolas; Josep Vidal-Alaball; Joan Gil; Francesc López; Catia Nicodemo; Marc Saez
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

9.  Characterization and Identification of Variations in Types of Primary Care Visits Before and During the COVID-19 Pandemic in Catalonia: Big Data Analysis Study.

Authors:  Francesc Lopez Segui; Guillem Hernandez Guillamet; Héctor Pifarré Arolas; Francesc X Marin-Gomez; Anna Ruiz Comellas; Anna Maria Ramirez Morros; Cristina Adroher Mas; Josep Vidal-Alaball
Journal:  J Med Internet Res       Date:  2021-09-14       Impact factor: 5.428

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.